Abstract
Polysaccharides are not degradable by proteolytic enzymes in lysosomes and do not diffuse through cellular membranes. Thus, attached to an internalizing, targeting protein, such polysaccharide linkers, will remain intracellularly after protein degradation. They can be labeled with halogens and provide then a so called residualizing label. Such an approach improves tumor-to-non-tumor radioactivity ratio and, consequently, the results of radionuclide diagnostics and therapy. In this study we present a new approach to obtain a stable halogenation of the polysaccharide dextran using 7-(3-amino-propyl)-7,8-dicarba-nido-undecaborate (-) (ANC). Dextran T10 was partially oxidized by metaperiodate, and ANC was coupled to dextran by reductive amination. The conjugate was then labeled with 125I using either Chloramine-T or IodoGen as oxidants. Labeling efficiency was 69-85%. Stability of the label was evaluated in rat liver homogenates. Under these conditions, the ANC-dextran conjugate was found to be more stable than labeled albumin, which was used as a control protein.
Similar content being viewed by others
References
B. A. Khaw, J. Cooney, T. Edingtom, H. W. Strauss, J. Nucl. Med., 27 (1986) 1293.
C. J. Turner, T. R.Sykes, B. M. Longenecker, A. A. Noujaim, Intern. J. Radiat. Appl. Instrum. B15 (1988) 701.
A. Bischof-Delaloye, B. Delaloye, F. Buchegger, C.-A. Vogel, M. Gillet, J.-P. Mach, A. Smith, P. A. Schubiger, J. Nucl. Med., 38 (1997) 847.
W. E. Meijs, H. J. Haisma, R. P. Klok, F. B. van Gog, E. Kievit, H. M. Pinedo, J. D. M. Herscheid, J. Nucl. Med., 38 (1997) 112.
B. van Deurs, O. W. Petersen, S. Olsnes, K. Samdvight, Intern. Rev. Cytol., 117 (1989) 131.
R. J. Kyriakos, L. B. Shih, G. L. Ong, K. Patel, D. M. Goldenberg, M. J. Mattes, Cancer Res., 52 (1992) 835.
F. Geissler, S. K. Anderson, P. Venkatesan, O. Press, Cancer Res., 52 (1992) 2907.
O. W. Press, D. Shan, J. Howell-Clark, J. Eary, F. R. Appelbaum, D. Matthews, D. J. King, A. M. Haines, P. Hamann, L. Hinman, D. Shochat, I. D. Bernstein, Cancer Res., 56 (1996) 2123.
R. C. Pittman, T. E. Carew, C. K. Glass, S. R. Green, C. A. Taylor, A. D. Attie, Biochem. J., 212 (1983) 791.
J. L. Strobel, J. W. Baynes, S. R. Thorpe, Arch. Biochem. Biophys., 240 (1985) 635.
S. R. Thorpe, J. W. Baynes, Z. C. Chroneos, FASEB J., 7 (1993) 399.
A. Andersson, J. Capala, J. Carlsson, J. Neurooncol., 14 (1992) 213.
J. Carlsson, E. Blomquist, L. Gedda, A. Liljegren, P. U. Malmstrom, A. Sjostrom, A. Sundin, J. E. Westlin, Q. Zhao, V. Tolmachev, H. Lundqvist, Acta Oncol., 38 (1999) 313.
L. B. Shih, S. R. Thorpe, G. L. Griffiths, H. Diril, G. L. Ong, H. J. Hansen, D. M. Goldenberg, M. J. Mattes, J. Nucl. Med., 35 (1994) 899.
A. L. Sundberg, E. Blomquist, J. Carlsson, A. C. Steffen, L. Gedda, Nucl. Med. Biol., 30 (2003) 303.
R. Stein, D. M. Goldenberg, S. R. Thorpe, M. J. Mattes, J. Nucl. Med., 38 (1997) 391.
C. J. Reist, G. E. Archer, S. N. Kurpad, C. J. Wikstrand, G. Vaidyanathan, M. C. Willingham, D. K. Moscatello, A. J. Wong, D. D. Bigner, M. R. Zalutsky, Cancer Res., 55 (1995) 4375.
D. S. Wilbur, D. K. Hamlin, J. C. Livesey, R. R. Srivastava, G. E. Laramore, T. W. Griffin, Nucl. Med. Biol., 21 (1994) 601.
D. S. Wilbur, D. K. Hamlin, R. R. Srivastava, J. Label. Comp. Radiopharm., 35 (1994) 199.
D. S. Wilbur, D. K. Hamlin, C. F. Foulon, M. R. Zalutsky, P. M. Pathare, J. Lab. Comp. Radiopharm., 40Suppl 1 (1997) 76.
D. S. Wilbur, D. K. Hamlin, P. M. Pathare, B. B. Kegley. J. Lab. Comp. Radiopharm., 42Suppl. 1 (1999) 288.
D. S. Wilbur, D. K. Hamlin, B. B. Kegley, M.-K. Chyan, P. M. Pathare, F. Wan, J. Lab. Comp. Radiopharm., 44 (2001) S973.
J. Malmqvist, S. SjÖberg, Synthesis of some 7,8-dicarbe-nido-undecaborate (-1) derived from o-aminoalkyl-1,2-dicarba-closo-dodecaboranes(12), in: J. Malmqvist, Ph.D. Thesis, Acta Universitatis Upsaliensis, Uppsala, 1995.
Q. Zhao, V. Tolmachev, J. Carlsson, H. Lundqvist, J. Sundin, J.-C. Janson, A. Sundin, Bioconjugate Chem., 10 (1999) 938.
A. Andersson, J. Capala, J. Carlsson, J. Neurooncol., 14 (1992) 213.
Q. Zhao, E. Blomquist, H. Bolander, L. Gedda, P. Hartvig, J. Janson, H. Lundqvist, H. Mellstedt, S. Nilsson, M. Nister, A. Sundin, V. Tolmachev, J. Westlin, J. Carlsson, Intern. J. Mol. Med., 1 (1998) 693.
P. K. Garg, K. L. Alston, M. R. Zalutsky, Bioconjugate Chem., 6 (1995) 493.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tolmachev, V., Bruskin, A., Sjöberg, S. et al. Preparation, radioiodination and in vitro evaluation of a nido-carborane-dextran conjugate, a potential residualizing label for tumor targeting proteins and peptides. Journal of Radioanalytical and Nuclear Chemistry 261, 107–112 (2004). https://doi.org/10.1023/B:JRNC.0000030942.76919.6b
Issue Date:
DOI: https://doi.org/10.1023/B:JRNC.0000030942.76919.6b